1 Division of Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114.
2 Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
AJR Am J Roentgenol. 2018 Feb;210(2):W80-W85. doi: 10.2214/AJR.16.17730. Epub 2017 Nov 7.
The purpose of this study is to evaluate the role of endovascular therapy in the management of venous thoracic outlet syndrome (TOS), with an emphasis on its role after surgical decompression.
This single-center retrospective review identified all patients who underwent conventional contrast-enhanced venography as a component of the imaging evaluation of clinically suspected venous TOS from January 2004 through September 2015. Eighty-one patients were identified, with a mean (± SD) age of 33 ± 12 years, of whom 59% (48/81) were women. After imaging confirmation of venous TOS, a standardized treatment protocol combining surgical and endovascular intervention was used for management.
Of the 81 patients included in the study, 73 (90%) had angiographic evidence of venous TOS; 41 of these 73 patients (56%) underwent endovascular venous intervention (e.g., thrombolysis or angioplasty before surgical) decompression. A total of 67 patients (67/73; 92%) with venous TOS underwent surgical decompression, with 56 of these (56/73; 77%) undergoing postoperative venography. Of these 56 patients who underwent postoperative venography, 48 (86%) required venoplasty, four had normal-appearing subclavian veins (7%) and had no intervention, and four of 48 (8%) had chronic total venous occlusions that could not be recanalized. Only four of the 48 of the patients (8%) who underwent postdecompression venoplasty required subsequent repeat venography and intervention for management of persistent or recurrent symptoms, whereas all others (44/48; 92%) remained symptom free on clinical follow-up. No complications were identified that were related to the endovascular interventions.
Combining venography and endovascular venous intervention with surgical decompression in managing patients with clinically suspected venous TOS is safe and effective. Postdecompression venoplasty appears to be highly effective, with a low rate of symptom recurrence.
本研究旨在评估血管内治疗在静脉型胸廓出口综合征(TOS)治疗中的作用,重点在于其在外科减压后的作用。
本单中心回顾性研究纳入了 2004 年 1 月至 2015 年 9 月期间因疑似静脉型 TOS 而接受常规对比增强静脉造影的所有患者。共 81 例患者,平均(±SD)年龄为 33±12 岁,其中 59%(48/81)为女性。在影像学证实静脉型 TOS 后,采用标准化的联合手术和血管内介入治疗方案进行治疗。
在纳入研究的 81 例患者中,73 例(90%)有静脉 TOS 的血管造影证据;其中 41 例(56%)在手术前进行了血管内静脉介入(如溶栓或血管成形术)减压。共 67 例(73 例中的 67 例;92%)患者进行了静脉减压手术,其中 56 例(73 例中的 56 例;77%)术后进行了静脉造影。在这 56 例接受术后静脉造影的患者中,48 例(86%)需要进行静脉成形术,4 例锁骨下静脉外观正常(7%),无需干预,48 例中有 4 例(8%)慢性完全性静脉闭塞无法再通。仅 4 例(8%)接受减压后静脉成形术的患者因持续或复发症状需要再次静脉造影和介入治疗,而其余患者(44/48;92%)在临床随访中均无症状。未发现与血管内介入相关的并发症。
在治疗疑似静脉型 TOS 的患者时,将静脉造影和血管内静脉介入与外科减压相结合是安全有效的。减压后静脉成形术效果显著,症状复发率低。